DIA RSIDM Forum (Regulatory Submissions, Information & Document Management)
Conference Focus
eCTD 4.0, IDMP, structured content, regulatory data governance, AI in submissions
Overview
The DIA Regulatory Submissions, Information & Document Management (RSIDM) Forum is a premier annual event organized by the Drug Information Association (DIA). It serves as a critical nexus for professionals navigating the complex landscape of global regulatory submissions. The forum focuses on the practical application of evolving standards, including eCTD 4.0 implementation, IDMP compliance, and the integration of AI within regulatory workflows. By bridging the gap between policy and technical execution, the event provides a unique platform for industry stakeholders to align on data governance and structured content strategies. This forum is significant for its role in facilitating direct dialogue between industry experts and regulatory authorities. It addresses the challenges of digital transformation in regulatory affairs, offering insights into how emerging technologies and data standards are reshaping the submission lifecycle. Attendees gain actionable knowledge on optimizing document management processes and ensuring data integrity, making it an essential gathering for those responsible for the submission and maintenance of regulatory dossiers.
Why Attend
Professionals should attend to gain firsthand insights into upcoming regulatory mandates and technical standards like eCTD 4.0. The forum offers unparalleled networking with peers and regulators, fostering a collaborative environment to solve complex submission challenges. Attendees will walk away with strategic roadmaps for implementing AI and data governance, directly enhancing their organization's operational efficiency and compliance posture.
Key Topics & Sessions
- •eCTD 4.0 Implementation Strategies
- •IDMP (Identification of Medicinal Products) Readiness
- •AI and Machine Learning in Regulatory Submissions
- •Regulatory Data Governance and Quality
- •Structured Content Management
- •Global Submission Lifecycle Management
- •Regulatory Information Management (RIM) Systems
- •Health Authority Interaction and Expectations
- •Electronic Records and Signatures Compliance
- •Interoperability of Regulatory Systems
Who Should Attend
Conference History
DIA has a long-standing history of convening global experts to address regulatory challenges. The RSIDM Forum has evolved over many years to become the industry's benchmark event for technical regulatory topics, consistently adapting to the rapid pace of digital transformation and new ICH guidelines.
Venue & Location
Bethesda North Marriott Hotel & Conference Center, North Bethesda, Maryland.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About DIA RSIDM Forum (Regulatory Submissions, Information & Document Management)
DIA RSIDM Forum (Regulatory Submissions, Information & Document Management) is a in-person event scheduled for 2026-02-02 to 2026-02-04 in Bethesda North Marriott, North Bethesda, MD. The conference focuses on ectd 4.0, idmp, structured content, regulatory data governance, ai in submissions. This event is categorized under Regulatory & Compliance, AI & Machine Learning in Pharma in our conference directory.
The DIA Regulatory Submissions, Information & Document Management (RSIDM) Forum is a premier annual event organized by the Drug Information Association (DIA). It serves as a critical nexus for professionals navigating the complex landscape of global regulatory submissions. The forum focuses on the practical application of evolving standards, including eCTD 4.0 implementation, IDMP compliance, and the integration of AI within regulatory workflows. By bridging the gap between policy and technical execution, the event provides a unique platform for industry stakeholders to align on data governance and structured content strategies. This forum is significant for its role in facilitating direct dialogue between industry experts and regulatory authorities. It addresses the challenges of digital transformation in regulatory affairs, offering insights into how emerging technologies and data standards are reshaping the submission lifecycle. Attendees gain actionable knowledge on optimizing document management processes and ensuring data integrity, making it an essential gathering for those responsible for the submission and maintenance of regulatory dossiers.
Professionals attending conferences like DIA RSIDM Forum (Regulatory Submissions, Information & Document Management) gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
AI and machine learning continue to transform the pharmaceutical industry, from drug discovery to commercial operations. Conferences featuring AI content provide valuable exposure to real-world implementations and emerging capabilities. Explore our Pharmaceutical GenAI Tracker for a comprehensive view of AI deployments across the industry.
Regulatory conferences are essential for staying current with evolving requirements from the FDA, EMA, and other global regulatory bodies. Understanding compliance frameworks such as 21 CFR Part 11 and ICH guidelines is critical for pharmaceutical software development and validation.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.